Best Peptides for Growth Hormone Research
Growth hormone research uses two distinct peptide classes: GHRPs (ghrelin receptor agonists like Ipamorelin and GHRP-6) and GHRH analogs (like CJC-1295 and Tesamorelin). These classes target different receptor systems — GHS-R1a and GHRH receptor — and are synergistic when combined. The most studied GHRP selectivity question is covered in the ipamorelin vs ghrp-6 comparison.
This guide covers all major GH axis peptides, their receptor mechanisms, selectivity profiles, and when each is appropriate. For direct comparisons, see Ipamorelin vs GHRP-6 and CJC-1295 vs Ipamorelin.
Common research queries include:
- —best peptide for growth hormone research
- —best GHRP for GH studies
- —ipamorelin vs ghrp-6 which is better
- —cjc-1295 vs ipamorelin combination
- —best GHRH analog for GH research
Best Peptides for Growth Hormone Research (Quick Picks)
Fast-answer guide for common GH research design questions.
What Makes a Peptide Best for Growth Hormone Research?
Growth hormone research distinguishes two receptor systems: GHS-R1a (targeted by GHRPs like Ipamorelin and GHRP-6) and GHRH receptor (targeted by GHRH analogs like CJC-1295). The right compound depends on which receptor pathway your protocol targets and whether selectivity, potency, or half-life duration is the primary design variable — see the Ipamorelin vs GHRP-6 selectivity comparison.
Half-life determines GH pulse pattern: episodic (GHRPs, ~1–2 hrs), moderate episodic (Tesamorelin, ~1–2 hrs), ultra-short (Sermorelin, ~10–20 min), or sustained (CJC-1295 DAC, ~7–8 days) — see CJC-1295 vs Tesamorelin for half-life context and the peptide half-life research guide.
Selectivity determines HPA axis involvement: Ipamorelin produces minimal cortisol co-stimulation while GHRP-2 produces moderate — see Ipamorelin vs GHRP-2. For combined GHRP + GHRH dual-pathway protocols, see CJC-1295 vs Ipamorelin.
Top Peptides for Growth Hormone Research
The most extensively studied GH axis peptides — organized by receptor class and research application.
Ipamorelin
Receptor
GHS-R1a (ghrelin receptor)
Half-Life
~2 hours
Selectivity
High — no cortisol/prolactin co-stimulation
- →Selective 3rd-gen GHS-R1a activation
- →Episodic clean GH pulse without HPA co-stimulation
- →Reference compound for GHRP selectivity research
GHRP-6
Receptor
GHS-R1a + ghrelin-related
Half-Life
~1–2 hours
Selectivity
Moderate — ghrelin/appetite co-activation
- →1st-gen GHS-R1a benchmark reference
- →Integrated ghrelin + hunger signaling pathway
- →Reference for GHRP generational comparison SAR
GHRP-2
Receptor
GHS-R1a (high potency)
Half-Life
~15–30 minutes
Selectivity
Lower — cortisol + prolactin co-stimulation
- →2nd-gen high-potency GHRP reference
- →Cortisol and ACTH co-stimulation included
- →Short-window high-intensity GHS-R1a activation
CJC-1295
Receptor
GHRH receptor (cAMP/PKA)
Half-Life
~7–8 days (DAC)
Selectivity
High — GHRH receptor specific, no HPA effects
- →DAC modification enables ~7–8 day active window
- →Sustained GH baseline elevation via GHRH-R
- →Most commonly studied GHRH analog for combination protocols
Tesamorelin
Receptor
GHRH receptor (cAMP/PKA)
Half-Life
~1–2 hours
Selectivity
High — GHRH receptor specific
- →Full-length 44aa GHRH with DPP-IV resistance
- →Episodic GHRH-like signaling pattern
- →Metabolic GH axis and visceral tissue research
Sermorelin
Receptor
GHRH receptor (cAMP/PKA)
Half-Life
~10–20 minutes
Selectivity
High — GHRH receptor specific
- →Shortest half-life GHRH analog (~10–20 min)
- →Truncated GHRH 1–29 fragment
- →Acute pituitary responsiveness testing baseline
GH Peptide Comparison Table
| Compound | Class | Receptor | Half-Life | Selectivity |
|---|---|---|---|---|
| Ipamorelin | GHRP (3rd gen) | GHS-R1a | ~2 hrs | High — no cortisol |
| GHRP-6 | GHRP (1st gen) | GHS-R1a + ghrelin | ~1–2 hrs | Moderate — appetite co-activation |
| GHRP-2 | GHRP (2nd gen) | GHS-R1a (high) | ~15–30 min | Lower — cortisol + prolactin |
| CJC-1295 | GHRH analog (DAC) | GHRH-R | ~7–8 days | High — GHRH-R specific |
| Tesamorelin | GHRH analog | GHRH-R | ~1–2 hrs | High — GHRH-R specific |
| Sermorelin | GHRH analog (truncated) | GHRH-R | ~10–20 min | High — GHRH-R specific |
Top GH Peptide Comparisons
Direct side-by-side comparisons for the most commonly researched GH axis compound pairs.
Selective 3rd-gen GHRP vs. 1st-gen reference benchmark
GHRH analog + GHRP dual-pathway GH axis protocol
Potency vs. selectivity — GHRP generational comparison
Second vs. first-generation GHRP potency benchmarking
Sustained DAC vs. episodic GHRH receptor signaling
Ghrelin receptor GHRP vs. GHRH analog cross-class comparison
GHS-R1a vs. GHRH receptor — complementary GH axis tools
Full-length GHRH analog vs. truncated GHRH fragment
How to Choose a GH Peptide for Your Research
For Selectivity
Ipamorelin
Highest GHS-R1a selectivity, no cortisol/prolactin co-stimulation, ~2 hr clean pulse.
Compare →For Sustained GH Elevation
CJC-1295 (DAC)
DAC modification extends GHRH receptor activity to ~7–8 days for sustained GH baseline research.
Compare →For Dual-Pathway
Ipamorelin + CJC-1295
GHS-R1a + GHRH-R activation through independent pathways — synergistic GH axis protocol.
Compare →Frequently Asked Questions
What is the difference between GHRPs and GHRH analogs?
GHRPs (Ipamorelin, GHRP-6, GHRP-2) activate GHS-R1a (ghrelin receptor) via calcium/PKC signaling for episodic GH pulses. GHRH analogs (CJC-1295, Tesamorelin, Sermorelin) activate GHRH receptors via cAMP/PKA for GH synthesis. They converge on GH release but through independent intracellular pathways — which is why they are synergistic when combined.
Why is Ipamorelin considered more selective than GHRP-6 or GHRP-2?
Ipamorelin activates GHS-R1a with minimal off-target receptor effects, producing no significant cortisol, ACTH, or prolactin co-stimulation. GHRP-6 co-activates ghrelin-related appetite pathways; GHRP-2 produces moderate cortisol and prolactin co-stimulation. This selectivity makes Ipamorelin the preferred GHRP when hormonal profile isolation is required.
Why do researchers combine CJC-1295 with Ipamorelin?
CJC-1295 (GHRH receptor) and Ipamorelin (GHS-R1a) activate GH release through independent receptor systems that converge on pituitary somatotroph GH secretion. Combining them produces synergistic GH release greater than either compound alone — a well-characterized dual-pathway GH axis model.
How does CJC-1295 DAC differ from standard CJC-1295?
The Drug Affinity Complex (DAC) modification enables albumin binding, extending CJC-1295's half-life from minutes (like natural GHRH) to approximately 7–8 days. This produces sustained GH baseline elevation rather than brief GHRH pulses, enabling research into prolonged GH axis stimulation.
Are these compounds approved for human use?
No. All compounds are research-grade peptides for laboratory investigation only. Not approved for human consumption. All handling must comply with applicable regulations.
Deep Dive: GH Peptide Research Guides
Mechanism guides, side effect profiles, and endpoint-specific comparisons for the most-studied GH peptide pairs.
→ Ipamorelin Mechanism of Action
GHS-R1a selectivity, pulsatile GH release, somatostatin resistance
→ GHRP-6 Mechanism of Action
First-gen receptor profile, appetite pathway, cortisol co-stimulation
→ Ipamorelin vs GHRP-6 Side Effects
Hormonal selectivity profile and research-relevant confounds
→ Ipamorelin vs GHRP-6 Results Timeline
Phase-by-phase GH pulse, IGF-1, and body composition markers
→ Ipamorelin vs GHRP-6 for Fat Loss
GH-driven lipolysis vs appetite confound in fat loss research
→ Ipamorelin vs GHRP-6 for Muscle Growth
GH/IGF-1/mTOR anabolic pathway and cortisol anti-anabolic variables
→ Sermorelin vs Ipamorelin for GH Optimization
GHRH receptor vs GHS-R1a, synthesis vs release
→ Sermorelin vs Ipamorelin Differences
Receptor class, half-life, mechanism, and somatostatin sensitivity
→ Sermorelin vs Ipamorelin Results
GH pulse size, IGF-1, and body composition outcomes compared
→ Sermorelin vs Ipamorelin Mechanism
GHRH receptor pathway vs GHS-R1a pathway deep dive
→ GHRP-2 vs GHRP-6 Differences
Potency, cortisol, appetite — 2nd gen vs 1st gen compared
→ GHRP-2 vs GHRP-6 Side Effects
Cortisol vs appetite — which confound matters more?
Explore Growth Hormone Research Compounds
Research Use Only
All content and products are intended for laboratory research use only. Not approved for human consumption. All handling must comply with applicable regulations.